STSS vs. AFIB, UTRS, VERO, GMVDF, IONM, TMDIF, AVGR, AEMD, TNON, and NURO
Should you be buying Sharps Technology stock or one of its competitors? The main competitors of Sharps Technology include Acutus Medical (AFIB), Minerva Surgical (UTRS), Venus Concept (VERO), G Medical Innovations (GMVDF), Assure (IONM), Titan Medical (TMDIF), Avinger (AVGR), Aethlon Medical (AEMD), Tenon Medical (TNON), and NeuroMetrix (NURO). These companies are all part of the "surgical & medical instruments" industry.
Sharps Technology (NASDAQ:STSS) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations, community ranking and profitability.
17.2% of Sharps Technology shares are held by institutional investors. Comparatively, 56.9% of Acutus Medical shares are held by institutional investors. 14.1% of Sharps Technology shares are held by company insiders. Comparatively, 3.5% of Acutus Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Sharps Technology has a net margin of 0.00% compared to Acutus Medical's net margin of -166.79%. Acutus Medical's return on equity of -35.31% beat Sharps Technology's return on equity.
Sharps Technology has higher earnings, but lower revenue than Acutus Medical.
In the previous week, Acutus Medical had 4 more articles in the media than Sharps Technology. MarketBeat recorded 6 mentions for Acutus Medical and 2 mentions for Sharps Technology. Acutus Medical's average media sentiment score of 0.12 beat Sharps Technology's score of -0.04 indicating that Acutus Medical is being referred to more favorably in the news media.
Acutus Medical received 11 more outperform votes than Sharps Technology when rated by MarketBeat users. However, 100.00% of users gave Sharps Technology an outperform vote while only 32.43% of users gave Acutus Medical an outperform vote.
Sharps Technology has a beta of 1.03, indicating that its share price is 3% more volatile than the S&P 500. Comparatively, Acutus Medical has a beta of 0.19, indicating that its share price is 81% less volatile than the S&P 500.
Summary
Acutus Medical beats Sharps Technology on 7 of the 13 factors compared between the two stocks.
Get Sharps Technology News Delivered to You Automatically
Sign up to receive the latest news and ratings for STSS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding STSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sharps Technology Competitors List
Related Companies and Tools
